RECRUITING

Improving Genetic Counseling for BRCA+ Mothers

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Genetic counseling and testing for hereditary breast cancer may reveal that you, and possibly your blood relatives, are at increased risk for the disease across the lifespan. This includes biological children, both male and female. We do not yet know the best ways to educate mothers who have a risk gene (are BRCA+) about whether, when, and how to share genetic information with their children or manage their thoughts and feelings. The purpose of this study is to help mothers make more informed choices about talking with children about hereditary breast cancer, provide them with age-and gender-appropriate information and emotional support, and improve their psychological well-being.

Official Title

Parent Communication Study IV: Improving Genetic Counseling for BRCA+ Mothers

Quick Facts

Study Start:2020-07-01
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04258280

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Mothers/primary caregivers to adolescents/young adults ages 13-24 years-old.
  2. * Participating in genetic testing for hereditary breast cancer.
  3. * Adequately speak/read English.
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Kenneth Tercyak, PhD
CONTACT
202-687-0802
familycom@georgetown.edu

Study Locations (Sites)

MedStar Georgetown University Hospital
Washington, District of Columbia, 20007
United States

Collaborators and Investigators

Sponsor: Georgetown University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-07-01
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2020-07-01
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Cancer